ADC THERAPEUTICS
ADC Therapeutics is a clinical-stage oncology drug discovery and development company focused on advancing highly potent and targeted antibody-drug conjugates (ADCs) for the treatment of hematological cancers and solid tumors. Their ADCs are developed using the latest-generation pyrrolobenzodiazepine (PBD) dimer technology providing a superior therapeutic index compared to first-generation PBD ADCs in preclinical studies. PBD dimers are very potent toxins that actively kill cancer cells and have a differentiated mechanism of action than warheads commonly used in other ADCs.
ADC THERAPEUTICS
Industry:
Biopharma Biotechnology Medical Therapeutics
Founded:
2011-01-01
Address:
Lausanne, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.adctherapeutics.com
Total Employee:
251+
Status:
Active
Contact:
+1 908-731-5556
Email Addresses:
[email protected]
Total Funding:
691.55 M USD
Technology used in webpage:
Nginx Microsoft Exchange Online Amazon ReCAPTCHA Cloudflare Person Schema Cloudflare Hosting Gravatar Profiles Apple Mobile Web App Capable Cloudflare SSL
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Deerfield
Deerfield investment in Post-IPO Debt - ADC Therapeutics
Deerfield
Deerfield investment in Post-IPO Debt - ADC Therapeutics
Redmile Group
Redmile Group investment in Series E - ADC Therapeutics
Auven Therapeutics
Auven Therapeutics investment in Series E - ADC Therapeutics
AstraZeneca
AstraZeneca investment in Series E - ADC Therapeutics
Redmile Group
Redmile Group investment in Series E - ADC Therapeutics
Auven Therapeutics
Auven Therapeutics investment in Series E - ADC Therapeutics
AstraZeneca
AstraZeneca investment in Series E - ADC Therapeutics
Auven Therapeutics
Auven Therapeutics investment in Series D - ADC Therapeutics
AstraZeneca
AstraZeneca investment in Series D - ADC Therapeutics
Key Employee Changes
Date | New article |
---|---|
2022-06-13 | ADC Therapeutics Names David Gilman as Chief Business & Strategy Officer |
2022-05-09 | ADC Therapeutics Announces CEO Transition |
2020-04-21 | ADC Therapeutics Appoints Jennifer Creel as Chief Financial Officer |
Official Site Inspections
http://www.adctherapeutics.com Semrush global rank: 2.17 M Semrush visits lastest month: 9.11 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago